CWBHF Stock Chart & Stats
$0.24
$0.01(4.79%)
At close: 4:00 PM EDT
$0.24
$0.01(4.79%)
Day’s Range― - ―
52-Week Range$0.08 - $0.97
Previous CloseN/A
Volume97.28K
Average Volume (3M)472.23K
Market Cap
$87.96M
Enterprise Value$86.09
Total Cash (Recent Filing)$13.97M
Total Debt (Recent Filing)$13.03M
Price to Earnings (P/E)―
Beta0.35
Next Earnings
Nov 16, 2026EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.21
Shares Outstanding271,291,530
10 Day Avg. Volume333,657
30 Day Avg. Volume472,230
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)-28.04
Price to Sales (P/S)1.15
P/FCF Ratio-3.90
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.11
Revenue Forecast (FY)$34.18M
Bulls Say, Bears Say
Bulls Say
Manageable LeverageLow debt relative to equity reduces balance-sheet pressure and provides greater financial flexibility than a highly leveraged peer. This may help the company absorb operating volatility while it works toward restoring profitability and cash generation.
Multi-Channel Product PlatformA combination of e-commerce and wholesale distribution gives the company multiple routes to consumers, while its product range spans several wellness categories. This structure can support broader customer access and reduce reliance on one product or channel.
Established Branded PortfolioAn established branded portfolio can support repeat purchases, product extensions, and retailer recognition within the hemp-derived wellness market. Brand continuity also provides a platform for marketing multiple formats, including ingestibles, topicals, and pet products.
Bears Say
Declining RevenuePersistent revenue contraction indicates weakening demand, distribution, or product productivity and limits operating leverage. Without a durable return to growth, the company has less opportunity to spread fixed costs and rebuild profitability from its existing platform.
Deep Operating LossesLarge operating and net losses show that the current revenue base does not cover the company’s cost structure. Continued losses can erode equity, restrict investment in product and marketing initiatives, and make a sustainable path to profitability dependent on major restructuring.
Persistent Cash BurnNegative operating and free cash flow means the business is not yet self-funding and must rely on existing liquidity or external financing to sustain operations. Persistent cash consumption can reduce strategic flexibility and increase funding risk if losses continue.
Charlotte's Web Holdings News
CWBHF FAQ
What was Charlotte's Web Holdings’s price range in the past 12 months?
Charlotte's Web Holdings lowest stock price was $0.07 and its highest was $0.97 in the past 12 months.
What is Charlotte's Web Holdings’s market cap?
Charlotte's Web Holdings’s market cap is $87.96M.
When is Charlotte's Web Holdings’s upcoming earnings report date?
Charlotte's Web Holdings’s upcoming earnings report date is Nov 16, 2026 which is in 81 days.
How were Charlotte's Web Holdings’s earnings last quarter?
Charlotte's Web Holdings released its earnings results on Aug 13, 2026. The company reported -$0.02 earnings per share for the quarter, the consensus estimate of -$0.02 by $0.
Is Charlotte's Web Holdings overvalued?
According to Wall Street analysts Charlotte's Web Holdings’s price is currently Overvalued.
Does Charlotte's Web Holdings pay dividends?
Charlotte's Web Holdings does not currently pay dividends.
What is Charlotte's Web Holdings’s EPS estimate?
Charlotte's Web Holdings’s EPS estimate is -0.02.
How many shares outstanding does Charlotte's Web Holdings have?
Charlotte's Web Holdings has 271,291,530 shares outstanding.
What happened to Charlotte's Web Holdings’s price movement after its last earnings report?
Charlotte's Web Holdings reported an EPS of -$0.02 in its last earnings report, expectations of -$0.02. Following the earnings report the stock price went up 3.86%.
Which hedge fund is a major shareholder of Charlotte's Web Holdings?
Currently, no hedge funds are holding shares in CWBHF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Charlotte's Web Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth $64.8M over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
46.45%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-13.17%
Trailing 12-Months
Company Description
Charlotte's Web Holdings
Charlotte's Web Holdings, Inc. operates comprehensively in the hemp-derived cannabidiol (CBD) wellness market, covering cultivation, manufacturing, marketing, and sales. The company's extensive product line features liquid hemp extract oil tinctures, a variety of gummies designed for benefits such as sleep, stress relief, immune support, and post-exercise recovery, as well as easy-to-use capsules, topical CBD creams, and lotions. They also offer specialized products for pets. These offerings are available under recognized brands including Charlotte's Web, CBD Medic, CBD Clinic, and Harmony Hemp. Each product is formulated with naturally occurring phytocannabinoids, such as CBD, cannabichromene, cannabigerol, and cannabinol, alongside beneficial terpenes, flavonoids, and other hemp compounds. Distribution occurs through various channels, including brick-and-mortar retail locations, healthcare providers, and direct-to-consumer sales via their online platform. The company is committed to advancing cannabinoid research; its CW Labs science division collaborates with the University at Buffalo's Center for Integrated Global Biomedical Sciences on a dedicated research program, and it also maintains a scientific partnership with McLean Hospital. Founded in 2013 as Stanley Brothers Holdings Inc., the company rebranded to Charlotte's Web Holdings, Inc. in July 2018 and is headquartered in Denver, Colorado.
CWBHF Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized several transformative, strategic positives — a balance-sheet‑clearing BAT transaction with fresh capital, federal Medicare pilot eligibility (Substance Access BEI) allowing full‑spectrum CBD access into accountable care channels, meaningful clinical progress via DeFloria's Phase II clearance, substantial cost reductions (SG&A down ~21% YoY and ~44.5% over two years), and improved operating loss and margin runways. These positives are tempered by ongoing regulatory uncertainty (including a potential November 2026 hemp provision that could severely constrain the market), persistent net losses (Q4 net loss $11.4M; full‑year net loss ~$29.7M), a nonrecurring $1.3M inventory charge that depressed reported margins, and liquidity dependence on shareholder approval of the BAT transaction. On balance, the call conveyed constructive momentum and multiple high‑impact catalysts that materially improve the company’s strategic position, while acknowledging meaningful near‑term risks and the gradual timing of revenue realization from Medicare pilots.View all CWBHF earnings summaries